← Evidence map

ArticleThe oncologist2022

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.

Xiuning Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 35536733